Co-Authors
This is a "connection" page, showing publications co-authored by Steven Galetta and Jennifer Frontera.
Connection Strength
5.904
-
Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States. Front Aging Neurosci. 2021; 13:690383.
Score: 0.957
-
A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. 2021 Jul 15; 426:117486.
Score: 0.945
-
Author Response: A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology. 2021 03 16; 96(11):549-550.
Score: 0.935
-
Author Response: A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology. 2021 03 16; 96(11):551.
Score: 0.935
-
Toxic Metabolic Encephalopathy in Hospitalized Patients with COVID-19. Neurocrit Care. 2021 12; 35(3):693-706.
Score: 0.935
-
A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology. 2021 01 26; 96(4):e575-e586.
Score: 0.906
-
Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review. Clin Neurol Neurosurg. 2021 08; 207:106760.
Score: 0.059
-
COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2. J Neuroimaging. 2021 09; 31(5):826-848.
Score: 0.059
-
Cerebrospinal fluid findings in patients with seizure in the setting of COVID-19: A review of the literature. Seizure. 2021 Jul; 89:99-106.
Score: 0.059
-
Cerebrospinal fluid in COVID-19: A systematic review of the literature. J Neurol Sci. 2021 02 15; 421:117316.
Score: 0.058
-
Pearls & Oy-sters: Leukoencephalopathy in critically ill patients with COVID-19. Neurology. 2020 10 20; 95(16):753-757.
Score: 0.056